Dr. Anthony Apicelli, M.D.
Claim this profileWashington University School of Medicine
Studies Skin Cancer
Studies Angiosarcoma
4 reported clinical trials
9 drugs studied
Area of expertise
1Skin Cancer
Stage I
Stage II
2Angiosarcoma
Affiliated Hospitals
Clinical Trials Anthony Apicelli, M.D. is currently running
Chemotherapy and Radiation
for Cutaneous Angiosarcoma
Angiosarcoma is a rare and aggressive form of soft tissue sarcoma. Prior work demonstrates very poor outcomes, with most patients developing metastatic disease and less than 50% surviving greater than 5 years. In other soft tissue sarcomas, the use of radiotherapy and/or chemotherapy have improved progression-free survival in patients undergoing limited, organ-sparing surgeries. Taxane chemotherapy has shown efficacy in patients with metastatic angiosarcoma, but this has not been tested in patients with localized disease. This study examines the efficacy of induction paclitaxel followed by concurrent chemoradiation therapy with paclitaxel prior to curative surgical resection.
Recruiting1 award Phase 1 & 27 criteria
ADI-PEG 20 + Ifosfamide + Radiotherapy
for Soft Tissue Sarcoma
In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy.
Recruiting1 award Phase 1 & 2
More about Anthony Apicelli, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Anthony Apicelli, M.D. has experience with
- Radiation Therapy
- Paclitaxel
- Research Blood Draw
- Proton GRID Radiotherapy
- ADI PEG20
- Ifosfamide
Breakdown of trials Anthony Apicelli, M.D. has run
Skin Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anthony Apicelli, M.D. specialize in?
Anthony Apicelli, M.D. focuses on Skin Cancer and Angiosarcoma. In particular, much of their work with Skin Cancer has involved Stage I patients, or patients who are Stage II.
Is Anthony Apicelli, M.D. currently recruiting for clinical trials?
Yes, Anthony Apicelli, M.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Anthony Apicelli, M.D. has studied deeply?
Yes, Anthony Apicelli, M.D. has studied treatments such as Radiation therapy, Paclitaxel, Research blood draw.
What is the best way to schedule an appointment with Anthony Apicelli, M.D.?
Apply for one of the trials that Anthony Apicelli, M.D. is conducting.
What is the office address of Anthony Apicelli, M.D.?
The office of Anthony Apicelli, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.